|
HS Code |
391905 |
| Generic Name | Dydrogesterone |
| Brand Names | Duphaston, Femoston |
| Drug Class | Progestogen |
| Chemical Formula | C21H28O2 |
| Molecular Weight | 312.45 g/mol |
| Route Of Administration | Oral |
| Major Indications | Menstrual disorders, threatened abortion, infertility, endometriosis, hormone replacement therapy |
| Atc Code | G03DB01 |
| Half Life | 5-20 hours |
| Metabolism | Hepatic (liver) |
| Excretion | Renal (urine) |
As an accredited Dydrogesterone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dydrogesterone packaging: White rectangular box, blue and yellow accents, labeled "Dydrogesterone 10mg", contains 30 film-coated tablets, with clear dosage information. |
| Shipping | Dydrogesterone is shipped in secure, leak-proof containers compliant with international regulations. It is protected from moisture, light, and extreme temperatures. Packaging is clearly labeled with handling and hazard information. Documentation includes Safety Data Sheets (SDS). Transit involves reliable courier services to ensure timely and safe delivery to authorized recipients. |
| Storage | Dydrogesterone should be stored at a controlled room temperature, typically between 15°C and 30°C (59°F to 86°F), away from moisture, heat, and direct sunlight. It should be kept in its original packaging to protect it from light and humidity. Ensure the medication is out of reach of children and pets and avoid storing it in the bathroom. |
|
Purity 99%: Dydrogesterone of purity 99% is used in hormone replacement therapy, where it ensures precise hormonal balance with minimal impurities. Molecular weight 328.46 g/mol: Dydrogesterone with molecular weight 328.46 g/mol is used in the treatment of dysfunctional uterine bleeding, where it guarantees targeted progestogenic activity. Stability temperature 25°C: Dydrogesterone with a stability temperature of 25°C is used in oral tablet formulation, where it maintains efficacy during standard pharmaceutical storage. Melting point 196°C: Dydrogesterone featuring a melting point of 196°C is used in controlled-release dosage forms, where it provides thermal stability during manufacturing. Particle size <10 μm: Dydrogesterone with particle size less than 10 μm is utilized in micronized formulations, where it enhances bioavailability by increasing surface area. Chirality (S-enantiomer): Dydrogesterone with S-enantiomer chirality is employed in infertility management, where it offers superior receptor selectivity for improved therapeutic outcomes. Water solubility 0.951 mg/L: Dydrogesterone with water solubility of 0.951 mg/L is used in aqueous suspension formulations, where it provides controlled dissolution rates. Optical rotation +24°: Dydrogesterone with optical rotation +24° is used in quality assurance of pharmaceutical products, where it verifies stereochemical integrity for regulatory compliance. |
Competitive Dydrogesterone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Dydrogesterone stands out as a synthetic hormone primarily used to address progesterone deficiencies. As someone who’s followed advancements in reproductive medicine and seen the confusion many patients have when faced with multiple hormone therapies, the story of dydrogesterone feels particularly relevant. Doctors often reach for this option when treating menstrual disorders, supporting pregnancy, or managing endometriosis. It works by mimicking the actions of natural progesterone, yet it has a chemical structure designed to reduce many side effects linked to older hormone therapies. For women frustrated with irregular cycles or unexplained infertility, this can be a turning point. Unlike some traditional synthetic progestogens, dydrogesterone doesn’t lead to water retention or the mood disturbances that many people experience with older products.
Pharmaceutical companies supply dydrogesterone in tablet form. Most commonly, you’ll find 10 mg scored tablets, allowing for flexible dosing based on the regimen set by a healthcare practitioner. Having seen several patients at clinics struggle with daily routines involving multiple pills, the once-daily or twice-daily dosing of dydrogesterone offers some breathing room. The medicine has rapid absorption, and its effects kick in quickly, minimizing the waiting period for symptom relief. By contrast, some older progestogens or injections can linger in the body, leading to extended side effects.
Clinicians trust dydrogesterone in a variety of scenarios. Women dealing with secondary amenorrhea—when periods stop without clear reason—may benefit, especially if natural progesterone is out of balance. Fertility specialists also use dydrogesterone to prepare the uterine lining during assisted reproduction techniques. On a personal level, witnessing how a friend struggled through repeated miscarriages brought home the importance of well-timed hormone support; in some high-risk pregnancies or cases of repeated miscarriage, dydrogesterone plays a supportive role by creating a more stable hormonal environment for embryo implantation and early growth.
Physicians often compare dydrogesterone to micronized progesterone or medroxyprogesterone acetate. Unlike oral micronized progesterone, which can cause sedation or dizziness, dydrogesterone usually leaves people feeling clear-headed. Sometimes patients have to juggle their schedules around side effects—dydrogesterone relieves some of that pressure. It also carries less risk of androgenic effects—problems like acne or hair growth that many users of older drugs report.
It’s worth looking at the details that separate dydrogesterone from the alternatives. Medroxyprogesterone acetate, a widely used synthetic progestogen, can lead to metabolic changes, mood swings, and weight gain. For years, these side effects led some people to choose between symptom relief and quality of life. Dydrogesterone, on the other hand, shows high selectivity for progesterone receptors without triggering changes elsewhere in the body. I’ve seen women who appreciate being able to continue with daily activities—whether work or family responsibilities—without the disruption that other hormonal drugs bring.
Doctors also mention long-term safety. Studies highlight that dydrogesterone does not affect lipid metabolism or blood clotting the way some older progestins do, which matters for women with a family history of cardiovascular disease. This is one reason why many guidelines now recognize dydrogesterone as a safer option for medium- and long-term use.
It’s easy to get caught up in the technical language of drug inserts, but the reality is that any course of hormone therapy can affect a person’s mood, sleep, and sense of self. With dydrogesterone, many users report less bloating, fewer swings in emotion, and a sense that life continues as normal between doctor’s visits. For women hoping to conceive, it offers a chance to focus on the next steps rather than worrying about medication-induced symptoms. As someone who has family members who’ve been on various hormone treatments, these lived experiences remind me that it’s not just about clinical results—it’s about the impact on daily life.
Healthcare providers emphasize the importance of individualized plans. Dydrogesterone may not suit every person who needs hormone support, and doctors often check for allergies or interactions with other medications. The right dosage and duration depend heavily on the specific condition being treated—whether it’s period irregularities, endometrial protection, or early pregnancy loss. I’ve often heard doctors stress the value of follow-up visits: they monitor response, look for rare side effects, and adjust the regimen as needed. This personalized approach builds trust, and clear communication empowers patients to ask for help if something feels off.
As with all hormone medications, dydrogesterone requires honest conversations about potential risks alongside expected benefits. While many users tolerate it well, some still experience mild headaches or gastric upsets. Fortunately, reports of serious reactions are rare. Long-term safety data continue to emerge, and so far, it appears less likely to raise the risk of breast cancer or venous thromboembolism compared to some older hormones. People with personal or family histories of these conditions should talk openly with their doctors before starting treatment. This process of weighing risks and benefits feels familiar from everyday decisions—choosing the right medicine depends as much on values and priorities as on lab numbers.
For people in resource-limited settings, access to dydrogesterone sometimes presents a challenge. Supply chains, costs, and insurance coverage vary widely. The broader conversation about making essential medicines available to all highlights the need for healthcare systems to prioritize choices that improve both physical and emotional well-being. Lowering barriers to access—whether through generic options or smarter procurement—can help more people benefit from advances like dydrogesterone.
Anyone starting dydrogesterone should take it exactly as prescribed by their doctor. Tablets are typically swallowed with water, and taking them at the same time each day forms an easy-to-remember habit. For menstrual irregularities, the schedule often syncs with a particular part of the menstrual cycle. In cases of threatened miscarriage, treatment usually starts as soon as possible and continues for several weeks. Accuracy in following instructions directly impacts how well the therapy works. I’ve seen people keep medication diaries or set calendar reminders to stay on track. Simple tools like these can turn an intimidating new routine into something manageable.
A quick word about missed doses: if someone misses a tablet, most doctors recommend taking it promptly unless it’s almost time for the next dose. Doubling up to make up for a missed pill can cause unintended side effects. Open lines of communication with healthcare providers make all the difference here; pharmacists and nurses are invaluable for problem-solving small hiccups before they become big issues. The goal is to keep women healthy and confident—not bogged down by worries over missed doses.
Recent studies continue to examine the role of dydrogesterone in conditions like recurrent miscarriage and hormone replacement therapy. Researchers have documented successful outcomes in supporting pregnancy, especially in women with unexplained losses. Modern protocols using dydrogesterone align with efforts to provide more natural hormone profiles—reducing the peaks and valleys typical of older therapies. The cumulative clinical experience is starting to shift the standard of care, with many leading reproductive endocrinologists adopting dydrogesterone where appropriate.
As scientific understanding progresses, studies are also looking at new possibilities for dydrogesterone in gynecologic cancers and immunological disorders, though these uses remain experimental. Here, diligence matters; only robust, independent research can determine which indications truly benefit. Healthcare professionals stress that patients should rely on tested, approved uses, as experimentation outside established guidelines can be risky.
Stories from dydrogesterone users often spark broader discussions around reproductive rights, body autonomy, and the right to safe, effective medicine. Advocacy groups have drawn attention to the way hormone therapies shape everyday realities for women—whether in managing pain, restoring cycles, or pursuing parenthood. In my own community, conversations about hormones used to happen in whispers; greater visibility for evidence-based options like dydrogesterone brings these discussions out into the open.
Better education, both for patients and for healthcare professionals, leads to more empowered decisions and improved outcomes. Patients who know their options ask better questions, recognize side effects early, and advocate for themselves in ways that change the doctor-patient relationship for the better. For medical professionals, keeping up with new research and understanding patient experiences bridges the gap between science and real life.
Dydrogesterone has a track record stretching over sixty years. Over that time, millions have benefitted from its ability to manage gynecological issues with fewer troubling side effects. Drug regulators in many countries consider it a standard therapy for threatened miscarriage and luteal phase support. Looking at this kind of longevity, it’s clear that dydrogesterone fills a need that other drugs have struggled to meet. For today’s generation, having choices allows for tailored care without always compromising on comfort or personal priorities.
As research moves ahead, there’s potential for refining dydrogesterone’s use even further—optimizing dosing, finding new areas where its safety profile makes a real difference, and developing education tools that help both patients and doctors make better choices. I imagine a future where more medicines are designed not just for biological compatibility, but also for everyday living—a medicine that treats the whole person, not just the lab values.
Improving access remains a top priority. Lowering costs through greater availability of generics can make a big difference for families balancing healthcare with daily necessities. Governments and NGOs have a role to play, encouraging local manufacturing or streamlined import processes. For patients, clearer communication—about risks, benefits, and what to expect—lays the groundwork for better use. Having reliable information goes hand in hand with trust in the healthcare system.
Connecting patients to support groups and counseling can soften the emotional blow that sometimes comes with hormone therapy. Dealing with infertility, pregnancy complications, or chronic pain takes a toll, and sometimes finding a listening ear proves as important as the medication itself. Healthcare systems that support this holistic care—where physical and emotional needs are both respected—set the standard for thoughtful, effective medicine.
Training for healthcare professionals on the nuances of dydrogesterone therapy ensures that more practitioners can recognize who stands to benefit most. Regular continuing education keeps providers up to date on evolving research, changing side effect profiles, and new indications. This helps prevent both under-treatment and unnecessary risk, creating more value for the patient.
Clear labeling and straightforward instructions, available in multiple languages, can cut down on confusion and prevent common errors. These may sound like small steps, but they matter. Simple packaging that accommodates vision problems or low literacy builds in another layer of safety, especially in communities where educational resources are limited.
For many, using dydrogesterone becomes part of a pivotal life stage—managing fertility, navigating menstrual challenges, or planning for children. People's stories reveal that medical choices are about more than just numbers or diagnoses—they’re about relationships, self-image, and the freedom to plan for the future. Watching friends make these decisions has left a lasting impression; their journeys are marked not just by medical ups and downs, but also by hope, setbacks, and resilience.
As more people share their experiences, the collective knowledge around dydrogesterone grows. Online forums, patient groups, and doctor’s notes woven together paint a fuller picture of what it means to use this medication day in and day out. Building a culture that values shared experience could be one of the most important byproducts of modern hormone therapy.
The world of hormone therapy never stands still. Dydrogesterone, with its established safety record and patient-centered design, points to what future medications could look like: safe, targeted, and supportive of regular life. Ongoing research has the potential to uncover even better ways of using it, whether through tailored dosing or by identifying new groups who stand to benefit.
At the same time, it’s essential to resist the urge to oversell any one drug as a panacea. Informed decision-making, grounded in real clinical evidence and everyday experience, remains critical. Patients, families, and clinicians all have a voice. By keeping the focus on open dialogue, transparency, and dedication to patient welfare, the promise of dydrogesterone can reach its full potential—offering genuine benefits without compromise or confusion.
Dydrogesterone represents more than a line on a prescription pad or a label on a pharmacy shelf. It embodies decades of scientific progress and personal stories—women searching for answers, doctors seeking safer and more effective therapies, families hoping for new chances. As it gains recognition in everyday practice, access, education, and support remain at the heart of realizing its benefits. And for each patient who finds relief or new hope, the impact ripples outward—shaping not just medical outcomes, but life itself.